Sleep Apnea, ObstructiveFBT-CPAPNCT03432910
Application of Forced Breath Technique While CPAP Therapy for Apnea Classification
A study testing CPAP Titration using a Bilevel S/T mode with minimal pressure support and background rate in people with Sleep Apnea, Obstructive and Sleep Apnea, Central, run by Heinen und Löwenstein GmbH & Co. KG at 1 site in Germany.
Trial summary
This study analyzes the application of the Forced Breath Technique (FBT) to classify apneas during CPAP therapy with a prismaLAB (device name) therapy device. In this study the BiLevel ST (Spontaneous / Timed) therapy mode of the prismaLAB device is reduced to a CPAP pressure profile with exhalation relief by… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Sleep Apnea, Obstructive, Sleep Apnea, Central
- What is being tested?
- CPAP Titration using a Bilevel S/T mode with minimal pressure support and background rate
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteGermany
- Study dates
- 24 Mar 2016to 29 Mar 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- diagnosis of sleep-disordered breathing (AHI >= 15/h)
- ensued or indicated CPAP titration within a routine PAP therapy setting
- age >= 18 years
- presence of written informed consent
- in case of therapy control or repeated participation: total number of apneas in the ensued treatment night was > 10
Who cannot join
- written informed consent is missing
- Participation in another clinical trial that influences the initiation of (auto) CPAP treatment by specifications of device settings or titration procedure
- NYHA (New York Heart Association) class III or IV
- acute cardiac decompensation
- severe arrhythmia
- severe hypotension, particularly in combination with intravascular volume depletion
Show all 23Show fewer
- severe epistaxis
- high risk of barotrauma
- decompensated pulmonary conditions
- pneumothorax or pneumomediastinum
- pneumocephalus
- cranial trauma
- status following brain surgery or surgical intervention on the pituitary gland or the middle/inner ear
- acute sinus infection (sinusitis), middle ear infection (otitis media) or perforated eardrum
- dehydration
- Data of patients who completed the study protocol will be excluded from statistical analysis if one of the following criteria applies:
- there is leakage of > 50 l/min for
- application of incorrect device settings
- insufficient data quality of PSG (Polysomnography) -acquisition
- the device was applied outside range of indication
- data of diagnostic night are not acquired as a PSG
- informed consent isn´t present
- the total number of apneas during the treatment night with BiLevel ST is < 10
Trial locations and contacts
1 site in 1 country.
Germany1 site, 1 recruiting
- Recruiting
HELIOS Klinik
Hagen, North Rhine-Westphalia, 58091
Ulrike Domanski
About this study
Official title: Study of Application of Forced Breath Technique While CPAP Therapy for Apnea Classification
This study analyzes the application of the Forced Breath Technique (FBT) to classify apneas during CPAP therapy with a prismaLAB (device name) therapy device.
In this study the BiLevel ST (Spontaneous / Timed) therapy mode of the prismaLAB device is reduced to a CPAP pressure profile with exhalation relief by minimization of the pressure gap between exhalation and inhalation pressure.
The FBT based apnea classification of the devices firmware is matched with the by hand scoring of the polysomnographic data that is usually used to evaluate the quality of patients sleep.
Read the detailed description
Obstructive sleep-disordered breathing is usually treated by positive airway pressure (PAP) therapy with respective devices.The devices detect, classify and store respiratory events as apneas, hypopneas and snoring to adapt the therapy pressure according to patients needs and/ or to validate therapy efficacy.
Since several years the Forced Breath Technique (FBT) is standard practice in PAP devices with a BiLevel pressure profile and a background rate to classify apneas as central or obstructive. In case of an interruption of the respiratory flow within an apnea the devices background rate applies so called "mandatory breaths" with neither a manually or by device defined pressure gap between exhalation and inhalation pressure (PDIFF). If a mandatory breath generates respiratory flow patients airways are open and the patient gets ventilated. In this case the detected apnea is classified as central. If a mandatory breath generates no or insufficient respiratory flow patients airways are impassable and the apnea is classified as an obstructive event.
Usually the size of the applied therapeutic pressure gap PDIFF is >= 4 hPa. If patients airways are open the mandatory breaths with PDIFF>= 4 hPa generate an obvious flow that submits a valid classification of apneas. Therefore the pressure gap should be preferably large. So, too, the pressure gap size should be defined as small as possible to prevent the impairment of patients sleep quality.
This pilot study targets to analyze if the application of FBT with a minor gap between inhalation and exhalation pressure (IPAP [inspiratory positive airway pressure] - EPAP [expiratory positive airway pressure] = PDIFF = 1,0 to 2,0 hPa) qualifies for an equal classification of apneas as with a PDIFF >= 4 hPa. Subsequently it serves to define the minimum size of this pressure gap.
To this effect the study is subdivided in to phases: an optimization phase and an evaluation phase.
The optimization phase targets to define the PDIFF size that enables the valid classification of apneas. The evaluation phase serves to compute the accuracy of the classification, the optimized algorithm and the determined classification criteria. Therefore this phase only takes place if the optimization phase yielded a result.
The optimization phase starts with a PDIFF of 1,5 hPa. If this PDIFF serves the purpose, the phase continues with a PDIFF of 1,0 hPa to analyze if a smaller pressure gap yields similar results. Otherwise the phase continues with a PDIFF of 2,0 hPa. Afterwards the optimization phase ends.
The review of the matching of the apneas classified by the device vs the manual scoring takes place after the synchronization of both sources.
Within every PDIFF round in the optimization phase patient recruitment takes place as long as at least 60 obstructive and 60 central apneas have been collected. To guarantee an equal dispersion of apneas on the patient population only 10 obstructive and 10 central apneas of each patient go down in the pool of apneas of the respective PDIFF round. The apnea extraction is made by randomization.
The evaluation phase runs with the determined PDIFF until at least 80 obstructive and 80 central apneas are collected.
The data evaluation occurs by use of descriptive statistics and based on fourfold tables.
- Conditions
- Sleep Apnea, Obstructive, Sleep Apnea, Central
- Being tested
- CPAP Titration using a Bilevel S/T mode with minimal pressure support and background rate
- Keywords
- Forced Breath Technique, auto-CPAP, CPAP, Obstructive sleep apnea, central sleep apnea
- Medical subject headings
- Sleep Apnea, Obstructive, Sleep Apnea, Central
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CPAP Titration using a Bilevel S/T mode with minimal pressure support and background rateOther
The study performs within clinical routine with this exception that instead of the usually applied CPAP mode a modified BiLevel S/T mode is used. The modified BiLevel S/T mode meets the same requirements as the CPAP mode while providing the Forced Breath Technique to classify apneas as central or obstructive.
| Study group | Role | What they receive |
|---|---|---|
| treatment group | Other | Participants of the study undergo the standard stages of the clinical routine within a PAP therapy setting: a diagnostic night followed by one or two treatment nights. Receives: Other: CPAP Titration using a Bilevel S/T mode with minimal pressure support and background rate |
What is being measured
The primary outcome is the main question the study is designed to answer.
Accuracy of the mapping of apneas based on the Forced Breath Technique compared to the manual scoring of polysomnographic data
Measured: 1 night (= first treatment night)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Feb 2018
- Study start24 Mar 2016
- Primary completion23 Feb 2018 (estimated)
- Study completion29 Mar 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sleep Apnea, ObstructiveStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Assignment
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Heinen und Löwenstein GmbH & Co. KG
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Löwenstein Medical Technology
- Responsible party
- Sponsor
- Investigators
- Georg Nilius, PD Dr. med., Principal investigator, HELIOS Klinik Hagen Ambrock
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03432910
- Sponsor's protocol ID
- 17-pLINE-FBT-C
- Acronym
- FBT-CPAP
- Status last verified
- Feb 2018
- First submitted
- 5 Feb 2018
- Last updated
- 14 Feb 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Feb 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of Application of Forced Breath Technique While CPAP Therapy for Apnea Classification
- ClinicalTrials.gov ID
- NCT03432910
- Acronym / sponsor ID
- FBT-CPAP / 17-pLINE-FBT-C
- Conditions
- Sleep Apnea, Obstructive, Sleep Apnea, Central
- Keywords
- Forced Breath Technique, auto-CPAP, CPAP, Obstructive sleep apnea, central sleep apnea
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Heinen und Löwenstein GmbH & Co. KGIndustry (pharma, biotech, devices)
- Collaborators
- Löwenstein Medical Technology
- Study start
- 24 Mar 2016 (actual)
- Primary completion
- 23 Feb 2018 (estimated)
- Study completion
- 29 Mar 2018 (estimated)
- First posted
- 14 Feb 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study analyzes the application of the Forced Breath Technique (FBT) to classify apneas during CPAP therapy with a prismaLAB (device name) therapy device.
In this study the BiLevel ST (Spontaneous / Timed) therapy mode of the prismaLAB device is reduced to a CPAP pressure profile with exhalation relief by minimization of the pressure gap between exhalation and inhalation pressure.
The FBT based apnea classification of the devices firmware is matched with the by hand scoring of the polysomnographic data that is usually used to evaluate the quality of patients sleep.
Detailed description
Obstructive sleep-disordered breathing is usually treated by positive airway pressure (PAP) therapy with respective devices.The devices detect, classify and store respiratory events as apneas, hypopneas and snoring to adapt the therapy pressure according to patients needs and/ or to validate therapy efficacy.
Since several years the Forced Breath Technique (FBT) is standard practice in PAP devices with a BiLevel pressure profile and a background rate to classify apneas as central or obstructive. In case of an interruption of the respiratory flow within an apnea the devices background rate applies so called "mandatory breaths" with neither a manually or by device defined pressure gap between exhalation and inhalation pressure (PDIFF). If a mandatory breath generates respiratory flow patients airways are open and the patient gets ventilated. In this case the detected apnea is classified as central. If a mandatory breath generates no or insufficient respiratory flow patients airways are impassable and the apnea is classified as an obstructive event.
Usually the size of the applied therapeutic pressure gap PDIFF is >= 4 hPa. If patients airways are open the mandatory breaths with PDIFF>= 4 hPa generate an obvious flow that submits a valid classification of apneas. Therefore the pressure gap should be preferably large. So, too, the pressure gap size should be defined as small as possible to prevent the impairment of patients sleep quality.
This pilot study targets to analyze if the application of FBT with a minor gap between inhalation and exhalation pressure (IPAP [inspiratory positive airway pressure] - EPAP [expiratory positive airway pressure] = PDIFF = 1,0 to 2,0 hPa) qualifies for an equal classification of apneas as with a PDIFF >= 4 hPa. Subsequently it serves to define the minimum size of this pressure gap.
To this effect the study is subdivided in to phases: an optimization phase and an evaluation phase.
The optimization phase targets to define the PDIFF size that enables the valid classification of apneas. The evaluation phase serves to compute the accuracy of the classification, the optimized algorithm and the determined classification criteria. Therefore this phase only takes place if the optimization phase yielded a result.
The optimization phase starts with a PDIFF of 1,5 hPa. If this PDIFF serves the purpose, the phase continues with a PDIFF of 1,0 hPa to analyze if a smaller pressure gap yields similar results. Otherwise the phase continues with a PDIFF of 2,0 hPa. Afterwards the optimization phase ends.
The review of the matching of the apneas classified by the device vs the manual scoring takes place after the synchronization of both sources.
Within every PDIFF round in the optimization phase patient recruitment takes place as long as at least 60 obstructive and 60 central apneas have been collected. To guarantee an equal dispersion of apneas on the patient population only 10 obstructive and 10 central apneas of each patient go down in the pool of apneas of the respective PDIFF round. The apnea extraction is made by randomization.
The evaluation phase runs with the determined PDIFF until at least 80 obstructive and 80 central apneas are collected.
The data evaluation occurs by use of descriptive statistics and based on fourfold tables.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Assignment
| Arm | Type | Receives |
|---|---|---|
| treatment group | Other | Other: CPAP Titration using a Bilevel S/T mode with minimal pressure support and background rateParticipants of the study undergo the standard stages of the clinical routine within a PAP therapy setting: a diagnostic night followed by one or two treatment nights. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- diagnosis of sleep-disordered breathing (AHI >= 15/h)
- ensued or indicated CPAP titration within a routine PAP therapy setting
- age >= 18 years
- presence of written informed consent
- in case of therapy control or repeated participation: total number of apneas in the ensued treatment night was > 10
Key exclusion criteria (23 listed)
- written informed consent is missing
- Participation in another clinical trial that influences the initiation of (auto) CPAP treatment by specifications of device settings or titration procedure
- NYHA (New York Heart Association) class III or IV
- acute cardiac decompensation
- severe arrhythmia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CPAP Titration using a Bilevel S/T mode with minimal pressure support and background rateThe study performs within clinical routine with this exception that instead of the usually applied CPAP mode a modified BiLevel S/T mode is used. The modified BiLevel S/T mode meets the same requirements as the CPAP mode while providing the Forced Breath Technique to classify apneas as central or obstructive. | Other | treatment group |
Primary outcome
Accuracy of the mapping of apneas based on the Forced Breath Technique compared to the manual scoring of polysomnographic data
Time frame: 1 night (= first treatment night)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Feb 2018.
Related trials for Sleep Apnea, Obstructive
RecruitingObservational study
Development and Validation of a Multimodal Deep Learning Model Using Peripheral Oxygen Saturation and Ballistocardiography Signals for Predicting Apnea-Hypopnea Index in Obstructive Sleep Apnea
Obstructive Sleep Apnea
RecruitingPhase 3
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
Apnea, Sleep Disorders
Not yet recruitingPhase 2
Supplemental Oxygen for Sleep-Disordered Breathing in Adults With Chronic Opioid Use.
Sleep-disordered Breathing, Chronic Opioid Use
Recruiting
Nightly Wearable Monitoring During Home-Based Submental Electrical Stimulation for Obstructive Sleep Apnea
Obstructive Sleep Apnea
RecruitingPhase 1/2
DRonabinol Treatment of OSA
Obstructive Sleep Apnea
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Georg Nilius, PD Dr. med. principal investigator
HELIOS Klinik Hagen Ambrock
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing CPAP Titration using a Bilevel S/T mode with minimal pressure support and background rate in people with Sleep Apnea, Obstructive and Sleep Apnea, Central, run by Heinen und Löwenstein GmbH & Co. KG at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 23 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Regina Schaefer (+49 721-82830-23, regina.schaefer@loewensteinmedical.de), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Accuracy of the mapping of apneas based on the Forced Breath Technique compared to the manual scoring of polysomnographic data (time frame: 1 night (= first treatment night)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2018.